KBL MERGER CORP. IV Uncategorized Contracts & Agreements

50 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter between 180 Life Science Corp. and Stephen H. Shoemaker (director) dated December 2, 2024 and effective December 3, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Offer Letter between 180 Life Science Corp. and Jay Goodman (director) dated October 25, 2024 and effective October 24, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Indemnity Agreement dated September 3, 2024 and effective September 5, 2024, between 180 Life Sciences Corp. and Sir Marc Feldmann
KBL MERGER CORP. IV
Biotechnology
DE
2024
Form of 180 Life Sciences Corp. Indemnity Agreement
KBL MERGER CORP. IV
Biotechnology
DE
2024
Offer Letter between 180 Life Science Corp. and Ryan L. Smith (director) dated March 5, 2024 and effective March 7, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Offer Letter between 180 Life Science Corp. and Omar Jimenez (director) dated March 4, 2024 and effective March 7, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Offer Letter between 180 Life Science Corp. and Blair Jordan (director) dated February 24, 2024 and effective February 28, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2023
Form of Placement Agent Agreement
KBL MERGER CORP. IV
Biotechnology
NY
2023
Amendment No. 1 to the Warrants, dated April 5, 2023, by and between 180 Life Sciences Corp. and the Selling Stockholder
KBL MERGER CORP. IV
Biotechnology
2023
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2023
Placement Agent Agreement, dated April 5, 2023, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners
KBL MERGER CORP. IV
Biotechnology
NY
2023
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
KBL MERGER CORP. IV
Biotechnology
DE
2023
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2022
Placement Agent Agreement, dated December 20, 2022, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2022
Placement Agent Agreement dated July 17, 2022, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners
KBL MERGER CORP. IV
Biotechnology
NY
2022
Debt Conversion Agreement dated September 30, 2021, by and between 180 Life Sciences Corp. and Dr. Lawrence Steinman and Sir Marc Feldmann
KBL MERGER CORP. IV
Biotechnology
DE
2021
Form of Lock-Up Agreement (August 2021 Offering)
KBL MERGER CORP. IV
Biotechnology
2021
Engagement Letter dated August 17, 2021 between 180 Life Sciences Corp. and Maxim Group LLC
KBL MERGER CORP. IV
Biotechnology
NY
2021
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
KBL MERGER CORP. IV
Biotechnology
DE
2021
Form of Director Nominee Offer Letter (May 2021)
KBL MERGER CORP. IV
Biotechnology
2021
First Amendment to Consultancy Agreement dated March 31, 2021, by and between 180 Life Sciences Corp. and Prof Jagdeep Nanchahal
KBL MERGER CORP. IV
Biotechnology
2021
Consultancy Agreement dated February 22, 2021, by and between 180 Life Sciences Corp. and Prof Jagdeep Nanchahal
KBL MERGER CORP. IV
Biotechnology
2021
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2021
Amendment to Engagement Letter between 180 Life Sciences Corp. and Maxim Group LLC dated February 18, 2021
KBL MERGER CORP. IV
Biotechnology
2021
Engagement Letter dated January 26, 2021 between 180 Life Sciences Corp. and Maxim Group LLC
KBL MERGER CORP. IV
Biotechnology
NY
2021
Amendment Agreement dated November 25, 2020
KBL MERGER CORP. IV
Biotechnology
2020
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
KBL MERGER CORP. IV
Biotechnology
DE
2020
Form of Tyche Backstop Agreement
KBL MERGER CORP. IV
Biotechnology
2019
Form of Lock-Up Agreement, by and between KBL and certain stockholders of the Company
KBL MERGER CORP. IV
Biotechnology
2019
Form of Support Agreement, by and between KBL and certain stockholders of the Company
KBL MERGER CORP. IV
Biotechnology
DE
2019
Letter Agreement by and between the Company and its officers and directors and certain securityholders
KBL MERGER CORP. IV
Biotechnology
2017
Rights Agreement, dated June 1, 2017, between the Company and Continental Stock Transfer & Trust Company
KBL MERGER CORP. IV
Biotechnology
NY
2017
UNDERWRITINGAGREEMENT between KBLMERGER CORP. IV and LADENBURGTHALMANN & CO. INC., B.RILEY & CO. LLC, FBRCAPITAL MARKETS & CO., and I-BANKERSSECURITIES INC. Dated:[______], 2017
KBL MERGER CORP. IV
Biotechnology
NY
2017
[Signaturepage follows]
KBL MERGER CORP. IV
Biotechnology
2017
RIGHTSAGREEMENT
KBL MERGER CORP. IV
Biotechnology
NY
2017
KBLMERGER CORP. IV INCORPORATEDUNDER THE LAWS OF DELAWARE RIGHT
KBL MERGER CORP. IV
Biotechnology
2017
[Signaturepage follows]
KBL MERGER CORP. IV
Biotechnology
2017